New IASLC Foundation Board Member
Posted: February 2018
Dr. Paoletti is the Chairman of the Board for Genmab, PsiOxus Therapeutics (Chairman of the Board), FORMA Therapeutics, and Nucana Biomed. He was formerly the first appointed president of GSK Oncology, where he was responsible for championing an organization of more than 2,000 professionals around the world dedicated to fighting the causes and effects of cancer. As the leader of the business unit, he had accountability for the overall oncology business within GSK and oversaw all activities from early drug discovery through clinical development, launch, and life cycle management. Dr. Paoletti has a degree in medicine from the University of Pisa (Italy), where he was professor of pulmonary diseases and authored more than 300 publications.
